Cargando…
The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on pa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228755/ https://www.ncbi.nlm.nih.gov/pubmed/21982508 http://dx.doi.org/10.1186/1471-2407-11-433 |
_version_ | 1782217864411873280 |
---|---|
author | Grossmann, Irene Klaase, Joost M Avenarius, Johannes KA de Hingh, Ignace HJT Mastboom, Walter JB Wiggers, Theo |
author_facet | Grossmann, Irene Klaase, Joost M Avenarius, Johannes KA de Hingh, Ignace HJT Mastboom, Walter JB Wiggers, Theo |
author_sort | Grossmann, Irene |
collection | PubMed |
description | BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on palliation of symptoms, which is not necessarily a resection of the primary tumor. Both situations motivate adequate staging before treatment in CRC. This prospective observational study evaluates the outcomes after the introduction of routine staging with abdominal CT before treatment. METHODS: In a prospective observational study of 612 consecutive patients (2007-2009), the ability of abdominal CT to find liver metastases (LM), peritoneal carcinomatosis (PC) and T4 stage in colon cancer (CC) was analysed. RESULTS: Advanced CRC was present in 58% of patients, mCRC in 31%. The ability to find LM was excellent (99%), cT4 stage CC good (86%) and PC poor (33%). In the group of surgical patients with emergency presentations, the incidences of both mCRC (51%) and locally advanced colon cancer (LACC) (69%) were higher than in the elective group (20% and 26% respectively). Staging tended to be omitted more often in the emergency group (35% versus 12% in elective surgery). CONCLUSIONS: The strengths of staging with abdominal CT are to find LM and LACC, however it fails in diagnosing PC. On grounds of the incidence of advanced CRC, staging is warranted in patients with emergency presentations as well. |
format | Online Article Text |
id | pubmed-3228755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32287552011-12-02 The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer Grossmann, Irene Klaase, Joost M Avenarius, Johannes KA de Hingh, Ignace HJT Mastboom, Walter JB Wiggers, Theo BMC Cancer Research Article BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on palliation of symptoms, which is not necessarily a resection of the primary tumor. Both situations motivate adequate staging before treatment in CRC. This prospective observational study evaluates the outcomes after the introduction of routine staging with abdominal CT before treatment. METHODS: In a prospective observational study of 612 consecutive patients (2007-2009), the ability of abdominal CT to find liver metastases (LM), peritoneal carcinomatosis (PC) and T4 stage in colon cancer (CC) was analysed. RESULTS: Advanced CRC was present in 58% of patients, mCRC in 31%. The ability to find LM was excellent (99%), cT4 stage CC good (86%) and PC poor (33%). In the group of surgical patients with emergency presentations, the incidences of both mCRC (51%) and locally advanced colon cancer (LACC) (69%) were higher than in the elective group (20% and 26% respectively). Staging tended to be omitted more often in the emergency group (35% versus 12% in elective surgery). CONCLUSIONS: The strengths of staging with abdominal CT are to find LM and LACC, however it fails in diagnosing PC. On grounds of the incidence of advanced CRC, staging is warranted in patients with emergency presentations as well. BioMed Central 2011-10-07 /pmc/articles/PMC3228755/ /pubmed/21982508 http://dx.doi.org/10.1186/1471-2407-11-433 Text en Copyright ©2011 Grossmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Grossmann, Irene Klaase, Joost M Avenarius, Johannes KA de Hingh, Ignace HJT Mastboom, Walter JB Wiggers, Theo The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title | The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title_full | The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title_fullStr | The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title_full_unstemmed | The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title_short | The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer |
title_sort | strengths and limitations of routine staging before treatment with abdominal ct in colorectal cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228755/ https://www.ncbi.nlm.nih.gov/pubmed/21982508 http://dx.doi.org/10.1186/1471-2407-11-433 |
work_keys_str_mv | AT grossmannirene thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT klaasejoostm thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT avenariusjohanneska thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT dehinghignacehjt thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT mastboomwalterjb thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT wiggerstheo thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT grossmannirene strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT klaasejoostm strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT avenariusjohanneska strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT dehinghignacehjt strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT mastboomwalterjb strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer AT wiggerstheo strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer |